EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway

Shangdong Mu, Qiusi Tian, Liangyu Shen

Technology and Health Care · 2024

DOI: 10.3233/thc-231256 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Technology and Health Care, 2024. Verfasst von Shangdong Mu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Health Science Center, 3201 Hospital of Xi'an Jiaotong University, Hanzhong, Shaanxi, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Kelch-Like ECH-Associated Protein 1, NF-E2-Related Factor 2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Nucleolar protein 16 (NOP16) is present in the protein complex of the nucleolus. The NOP16 promoter contains a c-Myc binding site, and the transcriptional regulation by c-Myc directly regulates NOP16 expression levels. OBJECTIVE: Dysregulation of NOP 16 is currently reported in only a small number of cancers. In this study, the expression profile of NOP 16 in hepatocellular carcinoma (LIHC) and its clinical significance were analyzed. METHODS: NOP16 expression in hepatocellular carcinoma (LIHC) and its relationship with the clinical characters of LIHC were examined using the Cancer Genome Atlas (TCGA), the Gene Expression comprehensive database (GEO), Kaplan-Meier survival analysis, univariate Cox analysis, multivariate Cox analysis, ROC curve analysis of KEGG enrichment, GSEA enrichment, in vitro experiments (e.g., siRNA interference of NOP16 expression in hepatoma cells, Keap1-Nrf2 pathway, cell cycle, cell apoptosis and Transwell assays), and LIHC single-cell sequencing (scRNA). RESULTS: Pan-cancer analysis revealed that NOP16 was highly expressed in 20 cancer types, including LIHC, and high NOP16 expression was an independent adverse prognostic factor in LIHC patients. The expression levels of NOP16 mRNA and protein were significantly increased in tumour tissues of LIHC patients compared to normal tissues. The functions of co-expressed genes were primarily enriched in the cell cycle and reactive oxygen species metabolism. The experimental results showed that knockdown of NOP16 activated the Keap/Nrf2 signalling pathway and inhibited the invasion, migration, and EMT progression of LIHC cells. LIHC scRNA-seq data showed that NOP16 was primarily expressed in T lymphocytes. CONCLUSIONS: NOP16 promoted cancer development in LIHC and caused an imbalance in Keap/Nrf2 signalling, which subsequently caused the aberrant expression of genes typical for EMT, cell cycle progression and apoptosis. NOP16 is a potential prognostic marker and therapeutic target for hepatocellular carcinoma progression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2Signal TransductionHumansEpithelial-Mesenchymal TransitionNuclear ProteinsDisease ProgressionMaleFemaleCell Line, TumorPrognosisApoptosisGene Expression Regulation, NeoplasticProto-Oncogene ProteinsProteasome Endopeptidase Complex

Stichwörter der Autor:innen

Keap1-Nrf2 pathwayNOP16bioinformaticshepatic cell liver cancer

Substanzen

Kelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2KEAP1 protein, humanNFE2L2 protein, humanNuclear ProteinsPSMD10 protein, humanProto-Oncogene ProteinsProteasome Endopeptidase Complex

Autor:innen und Institutionen

  • Department of Oncology, Health Science Center, 3201 Hospital of Xi'an Jiaotong University, Hanzhong, Shaanxi, China.
  • Department of Neurosurgery, Health Science Center, 3201 Hospital of Xi'an Jiaotong University, Hanzhong, Shaanxi, China.
  • Department of Anesthesia, Operation Center, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, China.

Zitieren

APA

Mu, S., Tian, Q., & Shen, L. (2024). NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway. Technology and Health Care. https://doi.org/10.3233/thc-231256

Vancouver

Mu S, Tian Q, Shen L. NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway. Technology and Health Care. 2024. doi:10.3233/thc-231256

BibTeX
@article{Mu2024,
  author = {Mu, Shangdong and Tian, Qiusi and Shen, Liangyu},
  title = {NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway},
  journal = {Technology and Health Care},
  year = {2024},
  doi = {10.3233/thc-231256}
}
Kostenlos starten →